DE602007002642D1 - Pyrrolidinderivate mit wirkung am glyt1-transporter - Google Patents

Pyrrolidinderivate mit wirkung am glyt1-transporter

Info

Publication number
DE602007002642D1
DE602007002642D1 DE602007002642T DE602007002642T DE602007002642D1 DE 602007002642 D1 DE602007002642 D1 DE 602007002642D1 DE 602007002642 T DE602007002642 T DE 602007002642T DE 602007002642 T DE602007002642 T DE 602007002642T DE 602007002642 D1 DE602007002642 D1 DE 602007002642D1
Authority
DE
Germany
Prior art keywords
effect
pyrrolidine derivatives
glyt1 transporter
glyt1
transporter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007002642T
Other languages
German (de)
English (en)
Inventor
Clare Louise Anderton
David Clapham
Trevor Raymond Keel
Leanda Jane Kindon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602007002642D1 publication Critical patent/DE602007002642D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602007002642T 2006-06-22 2007-06-20 Pyrrolidinderivate mit wirkung am glyt1-transporter Active DE602007002642D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0612420.0A GB0612420D0 (en) 2006-06-22 2006-06-22 Compounds
PCT/EP2007/056106 WO2007147831A1 (en) 2006-06-22 2007-06-20 Pyrrolidine derivatives having activity at the glyt1 transporter

Publications (1)

Publication Number Publication Date
DE602007002642D1 true DE602007002642D1 (de) 2009-11-12

Family

ID=36803732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007002642T Active DE602007002642D1 (de) 2006-06-22 2007-06-20 Pyrrolidinderivate mit wirkung am glyt1-transporter

Country Status (23)

Country Link
US (1) US20080070973A1 (https=)
EP (1) EP2041082B1 (https=)
JP (1) JP2009541261A (https=)
KR (1) KR20090019847A (https=)
CN (1) CN101506156A (https=)
AR (1) AR061554A1 (https=)
AT (1) ATE444288T1 (https=)
AU (1) AU2007263058A1 (https=)
BR (1) BRPI0713311A2 (https=)
CA (1) CA2655399A1 (https=)
CL (1) CL2007001808A1 (https=)
CR (1) CR10498A (https=)
DE (1) DE602007002642D1 (https=)
EA (1) EA200970044A1 (https=)
ES (1) ES2333918T3 (https=)
GB (1) GB0612420D0 (https=)
IL (1) IL195633A0 (https=)
MA (1) MA30522B1 (https=)
NO (1) NO20085412L (https=)
PE (1) PE20080380A1 (https=)
TW (1) TW200817322A (https=)
WO (1) WO2007147831A1 (https=)
ZA (1) ZA200810009B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
JP2010530397A (ja) * 2007-06-20 2010-09-09 グラクソ グループ リミテッド アミド形成の改善方法
AU2011261375B2 (en) 2010-06-04 2016-09-22 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
US20120035156A1 (en) * 2010-08-09 2012-02-09 Daniela Alberati Combination of glyt1 compound with antipsychotics
WO2019073052A1 (en) 2017-10-13 2019-04-18 Treeway Tw001 B.V. EDARAVONE SALT

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746959A (en) * 1953-06-02 1956-05-22 American Home Prod Diphenylethylenediamine-penicillin salt
US3145209A (en) * 1961-07-31 1964-08-18 Olin Mathieson Substituted aminophenyl-ethylamine derivatives
NZ237443A (en) * 1990-04-10 1993-11-25 Asta Medica Ag Phenalkylethylenediamine and aminomethyltetra hydroisoquinoline derivatives, platinum (ii) and (iv) complexes, methods of preparation and pharmaceutical compositions
GB0130696D0 (en) * 2001-12-21 2002-02-06 Smithkline Beecham Plc Chemical Compounds
FR2861070B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
PE20061156A1 (es) * 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina

Also Published As

Publication number Publication date
ATE444288T1 (de) 2009-10-15
ES2333918T3 (es) 2010-03-02
EP2041082A1 (en) 2009-04-01
JP2009541261A (ja) 2009-11-26
AU2007263058A1 (en) 2007-12-27
GB0612420D0 (en) 2006-08-02
MA30522B1 (fr) 2009-06-01
US20080070973A1 (en) 2008-03-20
IL195633A0 (en) 2009-09-01
CR10498A (es) 2009-03-20
WO2007147831A1 (en) 2007-12-27
TW200817322A (en) 2008-04-16
EA200970044A1 (ru) 2009-04-28
KR20090019847A (ko) 2009-02-25
BRPI0713311A2 (pt) 2012-03-06
ZA200810009B (en) 2009-11-25
CN101506156A (zh) 2009-08-12
CA2655399A1 (en) 2007-12-27
PE20080380A1 (es) 2008-05-31
NO20085412L (no) 2009-01-22
AR061554A1 (es) 2008-09-03
EP2041082B1 (en) 2009-09-30
CL2007001808A1 (es) 2008-01-18

Similar Documents

Publication Publication Date Title
EP1882684A4 (en) PYRROLIDINE DERIVATIVE OR SALT
BRPI0817313A2 (pt) Derivados do ácido tetrâmico e tetrônico halogenoalcóxispirocíclicos
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
DE502006007906D1 (de) Rauchartikelpackung mit ausschiebedurchgang
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
DE602006003575D1 (de) Schwenkzylinder
DE502007007044D1 (de) tsmaschinen mit Nebenstromkonfiguration
DE602006002527D1 (de) Versiegelungsvorrichtung
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
DE602006006395D1 (de) Versiegelungsgerät
EP1861115A4 (en) SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBIOTIC ACTIVITY
ITFI20050094A1 (it) Opercolatrice perfezionata
EP2261210A4 (en) 3-SUBSTITUTED SULPHONYLPIPERAZINE DERIVATIVE
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
DE602006004661D1 (de) Gestreckte Polyamidfilme
DE602007002642D1 (de) Pyrrolidinderivate mit wirkung am glyt1-transporter
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DE602006006605D1 (de) Einspritzleitung
DK1971588T3 (da) Tiglien-3-onderivater
ATE410372T1 (de) Wafervial mit internen zwischenlagen
DE602007008391D1 (de) Klappbares gestell

Legal Events

Date Code Title Description
8364 No opposition during term of opposition